Cite

HARVARD Citation

    Aung, W. et al. (2021). Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma. Journal of dermatological science. 101 (3), pp. 174-184. [Online]. 
  
Back to record